<?xml version="1.0" encoding="UTF-8"?>
<p class="p">A putative combination of dopaminergic antagonism and antioxidant activity of a compound which readily cross the blood-brain barrier could be of pharmaceutical interest especially when the compound is used for the treatment of behavioral disorders in the frame of an organic or degenerative mental disorder.</p>
